Tag Archives: FSANZ Standard 2.6.5

New WHO Guidelines on risk reduction of cognitive decline and dementia

https://www.who.int/mental_health/neurology/dementia/guidelines_risk_reduction/en/ Relevant to concerns about FSANZ Standard 2.6.5 which has allowed products such as Souvanaid® and Ceretain® to be self-assessed and promoted for the dietary management of Alzheimer’s dementia or related mild cognitive impairment. On supplements, WHO says: Vitamins B … Continue reading

Posted in Advertising, Choosing wisely, Complementary medicine, Natural Therapies | Tagged , , , , , , , , , | Leave a comment